510(k) · Cleared
ClearedRandox Microalbumin Control Level 1 and Control Level 2 (Liquid)
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Randox Laboratories, Ltd. · JJX Single (Specified) Analyte Controls (Assayed And Unassayed)
Cleared on Jul 11, 2012 as substantially equivalent to K072835 (Bio-Rad, Diagnostics Grp., 2007) after a 27-day review. Its family tree reaches back 3 generations to 1997.
- Decided
- Jul 11, 2012
- Review
- 27 days
- Class
- Class I
- Product code
- JJX
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 3 generations to K971954 (1997). No later device cites it as a predicate yet.
- Root · 3 generations backK971954 Liquichek Urine Chemistry Control (Cat.NO. 397,398)Bio-Rad · 1997
- 2 generations backK020817 Liquichek Urine Chemistry ControlBio-Rad Laboratories, Inc. · 2002
- 1 generation backK072835 Liquichek Microalbumin Control Level 1, Level 2, Control MinipakBio-Rad, Diagnostics Grp. · 2007
- This deviceK121746 Randox Microalbumin Control Level 1 and Control Level 2 (Liquid)Randox Laboratories, Ltd. · 2012
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K971954 | Liquichek Urine Chemistry Control (Cat.NO. 397,398) | Bio-Rad | 1997 | — |
| −2 | K020817 | Liquichek Urine Chemistry Control | Bio-Rad Laboratories, Inc. | 2002 | — |
| −1 | K072835 | Liquichek Microalbumin Control Level 1, Level 2, Control Minipak | Bio-Rad, Diagnostics Grp. | 2007 | — |
| 0 (this device) | K121746 | Randox Microalbumin Control Level 1 and Control Level 2 (Liquid) | Randox Laboratories, Ltd. | 2012 | — |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in JJX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K072835 | Liquichek Microalbumin Control Level 1, Level 2, Control MinipakSummary page 1…862.1660 4. PREDICATE DEVICE PROPRIETARY NAME AND 510 (k) NUMBER Predicate Device Proprietary Name: LIQUICHEKrM Microalbumnin Control Levels 1 and 2 510 (k) Number: K072835 5. INTENDED USE The Randox Microalbumin controls are designed for in vitro diagnostic use as assa… | 2007 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 15 years and passes through 4 companies; a new generation was cleared every 4.8 years on median.
- None of the 3 ancestors has a recall.
- 1 other device also cites its predicate K072835.
How does its category compare?
All JJX devicesJJX Single (Specified) Analyte Controls (Assayed And Unassayed): FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.
FDA decisions per year · JJX
2in 2017
2026 to Oct 25, outlined.
Median 510(k) review, days · JJX
31in 2016
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · JJX
1in 2021
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · JJX
22in 2025
MAUDE reports naming product code JJX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 6 | 53 | 3 | 2 |
| 2008 | 8 | 52 | 3 | 0 |
| 2009 | 17 | 80 | 0 | 1 |
| 2010 | 24 | 80 | 3 | 6 |
| 2011 | 19 | 62 | 2 | 62 |
| 2012 | 15 | 40 | 0 | 32 |
| 2013 | 19 | 37 | 0 | 51 |
| 2014 | 22 | 30 | 1 | 48 |
| 2015 | 11 | 65 | 1 | 67 |
| 2016 | 6 | 31 | 2 | 37 |
| 2017 | 2 | — | 0 | 19 |
| 2018 | 0 | — | 2 | 35 |
| 2019 | 0 | — | 0 | 82 |
| 2020 | 0 | — | 0 | 77 |
| 2021 | 0 | — | 1 | 43 |
| 2022 | 0 | — | 0 | 24 |
| 2023 | 0 | — | 0 | 22 |
| 2024 | 0 | — | 0 | 30 |
| 2025 | 0 | — | 0 | 22 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Randox Microalbumin Liquid Controls are designed for use as assayed quality control materials for the quantitative determination of albumin in human urine.
This in vitro diagnostic device is intended for prescription use only and can only be used by professionals.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K121746 · printed Nov 6, 2026
Cite this page
510(k) Report. “K121746: Randox Microalbumin Control Level 1 and Control Level 2 (Liquid).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K121746
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026